Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues
March 22nd, 2024
The present protocol describes the method for establishing a patient-derived xenograft (PDX) mouse model using human osteosarcoma tissue.
This study meticulously replaces the lateral progression of human osteosarcoma tissue growth in immunodeficient mice, providing a platform for studying the growth, drug resistance relapse and metastasis of osteosarcoma. We realize the procedural steps involved in establishing a patient derived xenograft model using human osteosarcoma tissue, thereby advising the preclinical research on osteosarcoma. This technical accuracy mimics human cancer and imitates primary tumor similarity, facilitating the exploration of osteosarcoma biology and the treatment efficacy.
To begin, take the freshly resected osteosarcoma tissues stored in the tissue protective solution. Rinse the osteosarcoma tissues twice with pre-cooled sterile physiological saline in a sterile hood. Then remove the areas of osteosarcoma tissue with bleeding and necrosis.
Using a scalpel, cut the cleaned osteosarcoma tissue in a tissue culture dish containing pre-cooled sterile physiological saline. Keep the tissue on ice. Now, place the nude mice on sterile surgical drapes.
Pinch the toes of the mice to ensure that they are completely anesthetized. Then secure the mouse in a lateral decubitus position. With a marker pen, mark the surgical incision site on the skin.
Use the scalpel to make a five millimeter incision from the skin to the subcutaneous tissues. Now hold ophthalmic tweezers in the left hand and lift the upper margin of the incision. Simultaneously, use a straight needle holder with the right hand to perform blunt dissection upward under the dermis of the mice.
With ophthalmic tweezers, hold the upper side skin of the incision. Then transplant the osteosarcoma tissue under the skin five millimeters above the incision margin. Suture the incision using surgical lines with two to three stitches for a five millimeter incision.
Transplanting femoral osteosarcoma tissue from a 15-year-old patient to P0, P1, P2 and P3 mice resulted in the successful creation of a patient-derived xenograft.
Overview
This protocol describes the establishment of a patient-derived xenograft (PDX) mouse model using human osteosarcoma tissue. This model allows for the study of osteosarcoma growth, drug resistance, and metastasis.
Key Study Components
Area of Science
- Oncology
- Translational Research
- Preclinical Models
Background
- Osteosarcoma is a common bone cancer in children and adolescents.
- Understanding its biology and treatment response is crucial for improving patient outcomes.
- Patient-derived xenograft models closely mimic human tumors.
- This study focuses on the procedural steps for establishing such models.
Purpose of Study
- To create a reliable PDX model for osteosarcoma research.
- To facilitate the investigation of tumor biology and treatment efficacy.
- To enhance preclinical research methodologies.
Methods Used
- Freshly resected osteosarcoma tissues are collected.
- Tissues are rinsed with sterile physiological saline.
- Areas of bleeding and necrosis are removed.
- The model is established in immunodeficient mice.
Main Results
- The PDX model successfully mimics human osteosarcoma growth.
- It provides insights into drug resistance and metastasis.
- The model demonstrates primary tumor similarities.
- It serves as a platform for future osteosarcoma studies.
Conclusions
- The established PDX model is a valuable tool for osteosarcoma research.
- It aids in understanding the complexities of tumor behavior.
- This model can significantly contribute to the development of new therapies.
